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A B S T R A C T
Purpose: To investigate the characteristics of the aetiologies of convulsive status epilepticus (CSE) in
Western China and to identify the relationships of these aetiologies with the prognoses.
Methods: Consecutive registration and prospective observation of 258 cases of CSE in the Sichuan
Epilepsy Center were performed from 1996 to 2010 to study the aetiology of CSE. The relationships of the
aetiologies with the demographics, outcomes and complications of CSE were analysed using a logistic
regression model.
Results: The mean age was 37.6  20.21 years. The majority of the CSE (62.4%) cases were acute
symptomatic cases, and the primary cause was central nervous system (CNS) infection (33.7%). Histories of
epilepsy were present in 51.9% of the patients. Pre-existing epilepsy occurred due to discontinuation or
reduction of antiepileptic drugs (AEDs) in 31.3% of the CSE patients. Anoxia/poisoning (p < 0.05, OR 8.0, 95%
CI 1.34–47.77) was an independent predictor of mortality. CNS infections (p < 0.001, OR 8.99, 95% CI 3.52–
22.92), cerebrovascular diseases (p =0.001, OR 6.75, 95% CI 2.11–21.61) and anoxia/poisoning (p < 0.01, OR
7.64, 95% CI 1.93–30.21) were the major risk factors for complications associated with CSE.
Conclusions: (1) Compared to developed countries, CNS infections seemed to be more likely to be the
cause of CSE in developing countries. (2) Noncompliance with AEDs among patients with epilepsy was a
prominent and avoidable trigger of CSE.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Status epilepticus (SE) is a frequent cause of neurological
emergencies,1 and the annual incidence rate of SE has been
estimated to be 5–61 per 100,000 people in the United States and
Europe.2–6 However, the majority of patients with epilepsy live in
developing countries, and the information from these regions is
limited.7 Studies of SE in developing countries are often retrospec-
tive, and very few prospective studies exits.1,8–12 Hui et al. reported
on SE in the Chinese population in Hong Kong.11 However,
apparent differences between the Chinese population in Hong
Kong and that of mainland China exist in terms of economics,* Corresponding author at: Lane 37#, Chengdu, Sichuan 610041, PR China.
Tel.: +86 028 85422549; fax: +86 028 85422549.
E-mail address: zhoudong6668@163.com (D. Zhou).
1 Both these authors contributed equally to this article and should be regarded as
co-ﬁrst authors.
http://dx.doi.org/10.1016/j.seizure.2014.05.015
1059-1311/ 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights rehealth care and education levels, and these differences might
inﬂuence the aetiologies and clinical proﬁles of SE. Currently, there
are no prospective studies of SE in the mainland.
SE is classiﬁed as convulsive status epilepticus (CSE) or non-
convulsive status epilepticus (NCSE). Because CSE is the most
common and life-threatening form of SE and because emergency
electroencephalography (EEG) is not always available in Main-
land China, we focused on CSE, which is more easily diagnosed
based on clinical ﬁndings. Furthermore, the importance of the
underlying causes of SE in determining the outcomes of SE has
increasingly been recognised, and there is evidence that
aetiology rather than SE per se is the major determinant of
outcome.11,13
The western part of China is an underdeveloped region with
relatively limited medical resources. Here, we report for the ﬁrst
time the aetiologic proﬁle of CSE in Western China and focus on its
relation to prognosis to optimise the treatment and prevention of
CSE.served.
Table 1
The demographic and clinical information of patients with CSE (n = 258).
Demographic Number of patients (%)
Gender
Male 151 (58.5%)
Age
<15 years 26 (10.1%)
65 years 35 (13.6%)
Living areas of patients
Rural population 122 (47.2%)
Urban population 136 (52.8%)
Having a history of epilepsy 134 (51.9%)
Number of AEDs
One 152 (58.9%)
Two 86 (33.3%)
Three or more 20 (7.8%)
CSE type
GCSE 216 (83.7%)
TSE 8 (3.1%)
CPS-GCSE 28 (13.2%)
GCSE, generalised convulsive status epilepticus; CPS-GCSE, complex partial
secondary generalised convulsive status epilepticus; TSE, tonic status epilepticus.
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From January 1996 to October 2010, patients of all ages with
CSE who were hospitalised in the Epilepsy Center of Sichuan
Province were consecutively registered. This centre process
approximately 140 outpatient consultations for epilepsy per
day; and 20 beds have been appropriated for inpatients with
epilepsy in the department of neurology, and 12 beds have
been appropriated in a closed neurological intensive care unit
(ICU).
Neurologists diagnosed all patients based primarily on clinical
symptoms, and the diagnoses were made when the patients met
either of the following criteria: (1) continuous tonic-clonic seizure
activity lasting 30 min or more, and (2) recurrent tonic-clonic
seizure activity lasting 30 min or more without full return of
consciousness.14 According to the 1981 ILAE classiﬁcation, CSE is
divided into 3 categories; i.e., generalised convulsive status
epilepticus (GCSE), complex partial secondary generalised convul-
sive status epilepticus (CPS-GCSE), and tonic status epilepticus
(TSE).15 Patients with non-epileptic attacks and non-convulsive SE
were excluded.
The aetiology of CSE is classiﬁed as follows: (1) acute
symptomatic CSE, i.e., SE occurring in patients with acute medical
or neurological illness; (2) remote symptomatic CSE, i.e., SE due to
conditions that result in static encephalopathies or antecedent
insults such as stroke; and (3) cryptogenic CSE, i.e., SE due to
conditions that are presumed to be symptomatic but with unclear
causes; and (4) established epilepsy (with or without noncompli-
ance).16 The speciﬁc aetiological causes of CSE include central
nervous system (CNS) infections, cerebrovascular disease, brain
tumours, trauma, metabolic disorders, discontinuation and reduc-
tion of antiepileptic drugs (AEDs), alcoholism, anoxia, poisoning,
deformities, degenerative and demyelinating diseases, etc. The
aetiologies were determined by medical history, physical exami-
nation, laboratory tests, and EEG and neuroimaging ﬁndings.
History of epilepsy was characterised by two or more unprovoked
seizures in the past regardless of whether the patient was on
treatment. Discontinuation or reduction of an antiepileptic drug
was determined based on disease history and/or monitoring of
plasma drug concentrations. Intoxication was determined by the
detection of toxins in the blood, urine or other excretions of the
patients.
Information about the eligible patients was consecutively
collected and entered into a previously designed database; this
information included clinical characteristics, investigative data,
treatment methods, and outcome at time of discharge. The clinical
data consisted of demographic details, history of coexisting
medical diseases, history of epilepsy, use of AEDs, type of CSE,
cause of CSE and complications following CSE. The investigative
data included physical examination, some laboratory tests (e.g.,
blood gas analysis, blood glucose and electrolyte levels, urinalysis,
tests of liver and renal function, and CSF examination), EEG, CT and
MRI ﬁndings whenever available. Continuous EEG monitoring and
therapeutic drug monitoring were not performed for all patients.
The outcomes were recovery or death at the time of discharge. The
database was audited periodically to ensure accuracy.
2.1. Statistical analyses
All statistical analyses were performed using SPSS 13.0
(Chicago, IL, USA). In the univariate analyses, the duration of
epilepsy was analysed as a continuous variable, and age, aetiology,
sex, history of epilepsy, and living area were analysed as
categorical variables. The rank sum test was used for continuous
variables, and the chi-square test was used for categorical
variables. The relationships of aetiology with the complicationsand outcomes of CSE were assessed using a logistic regression
model. Statistic signiﬁcance was deﬁned at the 0.05 level.
3. Results
A total of 272 patients with CSE were identiﬁed upon admission
to the hospital, and 258 fulﬁlled the entry criteria; fourteen
patients were excluded due to ﬁnal diagnoses of non-convulsive SE
(4 cases) or non-epileptic status (10 cases). Fifty-nine percent of
the cases were conﬁrmed with EEG (the average test duration was
15 min) and were deﬁned as positive if ictal or postictal rhythmic
discharges that were no explained by other causes were present.
One hundred ﬁfty-one (58.5%) patients were male. The average age
of the patients was 37.6 (SD 20.21 years, range 2–89 years), 10.1%
were <15 years of age, and 13.6% were 65 years of age. One
hundred and thirty-four (51.9%) patients had histories of epilepsy
with a mean duration of 5.25 years (range: 0.08–38), and 8 (3.1%)
patients has previously experienced SE (Table 1). Nearly three-
quarters of all patients required admission to the neurological ICU.
The aetiologies were acute symptomatic in 62.4% of the
patients, remote symptomatic in 13.2%, and cryptogenic in 8.1%
of the patients (Table 2). Forty-two cases were due to irregular
discontinuation or reduction of AEDs (AED noncompliance), which
accounted for 31.3% of the patients with pre-existing epilepsy. Of
the cases of acute symptomatic CSE, CNS infections (33.7%) were
the most common cause, followed by encephalitis (26.3%) and
tuberculous meningitis (3.2%). In nearly 13% of the patients, the
CSE resulted from brain trauma. Only 26 cases of CSE (10.1%) were
caused by cerebrovascular disease, and 6 (2.7%) cases were caused
by poisoning with the rodenticide, tetramethylene disulfotetra-
mine (TETS). Alcohol-related CSE was not common in these
patients (Table 3).
In this study, 144 (55.9%) patients exhibited complications
associated with CSE that included including hyperthermia,
hyperglycaemia, electrolyte disturbances, hypotension, cardiac
arrest, renal insufﬁciency, pulmonary infection, and respiratory
failure. CNS infections (p < 0.001, OR 8.99, 95% CI 3.52–22.92),
cerebrovascular diseases (p = 0.001, OR 6.75, 95% CI 2.11–21.61)
and anoxia/poisoning (p < 0.01, OR 7.64, 95% CI 1.93–30.21) were
the three major risk factors for complications associated with CSE.
More than 70% of the patients with CSE due to any of these three
causes experienced complications (Fig. 1). A total of 35 (15.9%)
patients were dead; of these 2 deaths were caused by TETS
intoxication. Among all aetiologies, only anoxia/poisoning
Table 2
Aetiology for 258 CSE patients.
Aetiology Number of patients (%) Dead (%) Alive (%)
Acute symptomatic 161 (62.4%) 27 (62.8%) 134 (62.3%)
Remote symptomatic 34 (13.2%) 8 (18.6%) 26 (12.1%)
Cryptogenic 21 (8.1%) 5 (11.6%) 16 (7.4%)
Established epilepsy 42 (16.3%) 3 (7.0%) 39 (18.1%)
Total 258 43 215
Table 3
Speciﬁc causes of CSE compared to outcomes in 258 cases.
Speciﬁc causes Number of patients (%) Dead (%) Alive (%)
CNS infection 87 (33.7%) 10 (23.2%) 77 (35.8%)
Encephalitis 68 (26.3%)
Tuberculous meningitis 9 (3.5%)
Purulent meningitis 6 (2.3%)
Brain cysticercosis 4 (1.5%)
AED noncompliance 42 (16.3%) 3 (7.0%) 39 (18.1%)
Brain trauma 34 (13.2%) 5 (11.6%) 29 (13.5%)
Cerebrovascular disease 26 (10.1%) 7 (16.3%) 19 (8.8%)
Anoxia/poisoning 17 (6.6%) 6 (14.0%) 11 (5.1%)
Metabolism/alcoholism 13 (5.0%) 3 (7.0%) 10 (4.7%)
Other 18 (7.0%) 4 (9.3%) 14 (6.5%)
Brain deformity 2 (0.8%)
Degenerative diseases 6 (2.3%)
Brain tumour 8 (3.1%)
Multiple sclerosis 2 (0.8%)
Cryptogenic 21 (8.1%) 5 (11.6%) 16 (7.4%)
Total 258 43 215
AEDs, antiepileptic drugs; CNS, central nervous system.
Table 4
The ﬁrst three leading causes of CSE in each speciﬁc age group.
Age group (n, %) The ﬁrst
n (%)
The second
n (%)
The third
n (%)
<15 (26, 10.1%) CNS infections
11 (42.3%)
AED noncompliance
5 (19.2%)
Unknown
reasons
5 (19.2%)
15–44 (145, 56.2%) CNS infections
53 (36.6%)
AED noncompliance
22 (15.2%)
Brain trauma
17 (11.7%)
45–64 (52, 20.1%) CNS infections
17 (32.7%)
AED noncompliance
12 (23.1%)
Brain trauma
9 (17.3%)
65 (35, 13.6%) Cerebrovascular
disease
11 (31.4%)
Brain trauma
7 (20.0%)
CNS infections
6 (17.1%)
AEDs, antiepileptic drugs; CNS, central nervous system.
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predictor of death.
The different age groups had signiﬁcantly different CSE
aetiologies (p = 0.003, x2 = 43.271). The ﬁrst leading cause of
CSE for patients younger than 65 years was CNS infection, which
accounted for 30–40% of the CSE cases in this age group. Notably,
10.1% of the patients were younger than 15 years in this study, and
the ﬁrst leading cause of CSE was CNS infection, which accounted
for 42.3% of the cases, whereas cerebrovascular disease was the
leading cause among patients older than 65 years (27.6%) (Table 4).
Signiﬁcant differences in the aetiologies of CSE were also found
between the genders (p = 0.00, x2 = 52.246). The gender-speciﬁc
distributions showed that CNS infection was a common aetiology
among women, while AED noncompliance and cerebrovascular
disease were the two leading causes among men (Fig. 2); however,
there were no signiﬁcant differences in the age-speciﬁc case
distributions between the men and the women (data not shown).
No signiﬁcant differences in aetiology were found in terms of
history of epilepsy, or living area (p > 0.05). From 1996 to 2010, the0 20 40 60 80 10 0
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Fig. 1. The occurrence of complications after CSE in each etiological cause group.
Among patients with CSE caused by CNS infection, cerebrovascular disease, or
anoxia/poisoning, more than 70% of them had complications.spectrum of aetiological causes of CSE did not exhibit any
signiﬁcant changes in Western China.
4. Discussion
CSE is a common form of SE,17,18 and it is accompanied by high
morbidity and mortality. This research ﬁrst adopted consecutive
registration and prospective observation to study the character-
istics of the aetiologies of CSE in Western China, which is a
developing region.
In this study, the acute symptomatic aetiology accounted for
62.4% of the aetiologies, and this ﬁnding is similar to the high
frequencies that have been reported in some hospital-based
studies in developing countries.10–12 Among the cases of acute
symptomatic CSE, the most common cause was CNS infection
(33.7%), particularly among patients younger than 65 years. This
ﬁnding is consistent with some domestic reports and reports from
other developing countries,1,12,19,20 in which CNS infection has
been reported to accounted for 28–67% of all aetiologies. However,
this ﬁnding contrasts sharply with ﬁndings from Hong Kong, the
United States and some developed regions of Europe in which
cerebrovascular disease was reported to the predominant cause,
and the frequencies of CNS infection-related aetiologies were
reported to be less than 20%.21–24 These differences may be
attributed to the high incidence of CNS infections, particularly
encephalitis and tuberculous meningitis, in some resource-poor
regions. Additionally, some previous research has reported that
CNS infection is an independent predictor of refractory SE and
associated complications and is also related to markedly poor
outcomes.11,25,26 Thus, it is reasonable to speculate that the
effective treatment of CNS infections could beneﬁt the treatment,
prevention and prognoses of CSE.0 20 40 60 80
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Fig. 2. Gender distribution of speciﬁc causes for CSE in 258 patients. CNS infection
was the most common cause for CSE in women while noncompliance with AEDs
and brain trauma were the ﬁrst two leading causes for men.
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(approximately 16% overall) admitted discontinuing or reducing
their AED regimens without medical advice, which was an
important trigger for CSE; this poor compliance was more common
among men than women. This problem cannot be ignored in either
developed or developing countries.1,22 Previous community-based
studies have suggested that approximately 4–11% of SE cases are
related to poor AED compliance.27–29 A previous study showed that
up to 75% of patients have histories of epilepsy.30 Several factors,
including a lack of understanding of epilepsy and its treatment,
might have contributed to this ﬁnding. For example, some patients
believed that long-term AED use can damage the brain, whereas
others thought that they were cured after taking AEDs for 1–2
months and thus stopped taking the medications. AED noncom-
pliance is a potentially preventable cause of SE, which reinforces
the importance of high quality epilepsy care. Such care should
include convenient health consultations, proper education and
sufﬁcient psychological support for patients with epilepsy to
improve their compliance with long-term treatments of this
chronic disease.
Traumatic brain injury was the third leading cause of CSE in the
present. Traumatic brain injury accounted for 13.2% of all cases,
and this percentage is higher than those that have been reported in
other countries.1,13,31 The majority of these patients were adult
males (who compose the major labour force of the society) and
victims of trafﬁc accidents. The latter ﬁnding might be related to
the high rate of trafﬁc accidents in China; over 100,000 people are
killed in trafﬁc accidents in China every year, which is more than
any other country in the world.32 Taking strong actions to reduce
these accidents may also be paramount to the prevention of CSE in
the future.
Age was an important factor in the distribution of aetiologies,
and the leading cause of CSE in patients older than 65 years was not
CNS infections but was cerebrovascular disease, which is consis-
tent with many previous studies.21–24 In this study, cerebrovascu-
lar disease was found to be one of the major risk factors for
complications of CSE, and cerebrovascular disease has been
reported to be an important cause of refractory SE.33 Additionally,
patients of advanced age were prone to develop a greater number
of complications of CSE, including pneumonia.29,34 Thus, the
aetiological ﬁndings for the elderly in this study indirectly suggest
that old age was related to poor outcome. With the ageing of the
population in China, the incidences of SE and its complications are
expected to rise.11
Among the 10.1% of patients younger than 15 years in this
study, the ﬁrst leading cause of CSE was CNS infection. It has been
reported that the causes of CSE in children vary across different age
groups; however, the most common cause is febrile convulsion,
which accounts for nearly half of the cases.35,36 Moreover, it has
also been reported that the ﬁrst leading cause of CSE with fever in
children is CNS infection.37,38 The West China Hospital is mainly
for adults, and we were unable to collect sufﬁcient information
about children; however, our limited data might indicate some
age-speciﬁc aetiologies in China that are similar to those reported
in previous studies.
In this research, six cases were caused by TETS poisoning; all of
these the patients suffered multiple organ failure, and two died.
TETS is a potent rodenticide that can produce CSE via non-
competitive g-aminobutyric acid (GABA) antagonism. Numerous
accidental and deliberate poisonings have been reported in China,
and such poisoning is associated with high incidences of refractory
SE and death. Sporadic cases of CSE have also been reported in
Hong Kong and the United States.39–42 Some patients had severe
diffuse cerebral dysfunction that was likely secondary to
prolonged seizure activity following exposure to TETS; thus, CSE
caused by TETS poisoning should not be ignored in China.The identiﬁcation of outcome-predictive factors could lower
the risks of under- and over-treatment in SE. In addition to CNS
infections and cerebrovascular diseases, anoxia/poisoning was a
predictive factor for death and complications associated with CSE,
and this ﬁnding substantiates previous reports.13,34 Additional
research is needed to further explore other outcome-predictive
factors.
Together, these ﬁndings suggest the following: (1) in contrast to
developed countries, CNS infection seems to be the most common
cause of CSE in developing countries; and (2) noncompliance with
AEDs is a prominent and avoidable trigger for patients with
histories of epilepsy.
This study has some limitations. First, the data were collected in
a provincial epilepsy centre, and although we believe that the
ﬁndings of this study to some extent reﬂect features of the
aetiologies of CSE in the population of Western China, multi-centre
studies would be useful. Second, this study was conducted in a
hospital that is mainly for adult patients; therefore, we were not
able to collect more information about patients younger than 15
years, who may exhibit different characteristics regarding the
aetiologies, clinical proﬁles and prognoses of CSE. Lastly, CSE may
represent only a proportion of all SE cases. Continuous EEG will be
helpful in the detection of NCSE and further studies.
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